Primary Site >> Colorectal Cancer
Gene >> CCR5
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Simulating genealogies of selected alleles in a population of variable size. PMID: 11556137 |
Ref: Transepithelial transport of HIV-1 by M cells is receptor-mediated. PMID: 12093918 |
Ref: Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma. PMID: 15856455 |
Ref: Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas. PMID: 17764010 |
Ref: Role of eotaxin-1 signaling in ovarian cancer. PMID: 19351767 Ref: Expression of chemokines and chemokine receptors in human colon cancer. PMID: 19446722 |
Ref: Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration. PMID: 20054600 |
Ref: Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancer. PMID: 21468700 Ref: CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRbeta in colorectal carcinoma. PMID: 22205974 |
Ref: Administration of 6-gingerol greatly enhances the number of tumor-infiltrating lymphocytes in murine tumors. PMID: 21792901 Ref: Tumor-derived chemokine CCL5 enhances TGF-beta-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. PMID: 22282655 |
Ref: Crucial involvement of the CCL3-CCR5 axis-mediated fibroblast accumulation in colitis-associated carcinogenesis in mice. PMID: 24510316 Ref: CD4(+) T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer. PMID: 25268580 Ref: A method for conducting suppression assays using small numbers of tissue-isolated regulatory T cells. PMID: 25729646 |
Ref: The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer. PMID: 25405854 Ref: Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration. PMID: 25671296 Ref: CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells. PMID: 25840792 |
Ref: Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients. PMID: 27070705 Ref: Blockade of the chemokine receptor, CCR5, reduces the growth of orthotopically injected colon cancer cells via limiting cancer-associated fibroblast accumulation. PMID: 27340784 Ref: [Phenotypic characteristics of LAP(+) CD4(+) T lymphocytes in colorectal cancer tissues]. PMID: 27531479 Ref: Advances in immunotherapeutic strategies for colorectal cancer commentary on: tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients by Halama et al. PMID: 28031821 |
Ref: Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer. PMID: 26719303 Ref: Role of LAP(+)CD4(+) T cells in the tumor microenvironment of colorectal cancer. PMID: 28210081 Ref: Loss of Fas expression and high expression of HLA-E promoting the immune escape of early colorectal cancer cells. PMID: 28521443 |
Ref: Wnt pathway activator TWS119 enhances the proliferation and cytolytic activity of human gammadeltaT cells against colon cancer. PMID: 29104081 Ref: Mast Cell-Dependent CD8(+) T-cell Recruitment Mediates Immune Surveillance of Intestinal Tumors in Apc(Min/+) Mice. PMID: 29382671 |